CA2383510A1 - Method for the therapeutic management of extrauterine proliferation of endometreial tissue, chronic pelvic pain and fallopian tube obstruction - Google Patents
Method for the therapeutic management of extrauterine proliferation of endometreial tissue, chronic pelvic pain and fallopian tube obstruction Download PDFInfo
- Publication number
- CA2383510A1 CA2383510A1 CA002383510A CA2383510A CA2383510A1 CA 2383510 A1 CA2383510 A1 CA 2383510A1 CA 002383510 A CA002383510 A CA 002383510A CA 2383510 A CA2383510 A CA 2383510A CA 2383510 A1 CA2383510 A1 CA 2383510A1
- Authority
- CA
- Canada
- Prior art keywords
- antagonist
- lhrh antagonist
- short
- induction treatment
- administration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
- A61P5/04—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin for decreasing, blocking or antagonising the activity of the hypothalamic hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
- A61P5/08—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH for decreasing, blocking or antagonising the activity of the anterior pituitary hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/26—Androgens
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US15547899P | 1999-09-23 | 1999-09-23 | |
US60/155,478 | 1999-09-23 | ||
PCT/EP2000/009212 WO2001021194A2 (en) | 1999-09-23 | 2000-09-20 | Method for the therapeutic management of endometriosis and fallopian tube obstruction |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2383510A1 true CA2383510A1 (en) | 2001-03-29 |
Family
ID=22555601
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002383510A Abandoned CA2383510A1 (en) | 1999-09-23 | 2000-09-20 | Method for the therapeutic management of extrauterine proliferation of endometreial tissue, chronic pelvic pain and fallopian tube obstruction |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP1214086A2 (no) |
JP (2) | JP2003509467A (no) |
KR (1) | KR100772852B1 (no) |
CN (2) | CN1376070A (no) |
AU (1) | AU769482B2 (no) |
BG (1) | BG66128B1 (no) |
BR (1) | BR0014198A (no) |
CA (1) | CA2383510A1 (no) |
HK (1) | HK1049117A1 (no) |
HU (1) | HUP0202741A3 (no) |
IL (1) | IL148185A0 (no) |
MX (1) | MXPA02002436A (no) |
NO (1) | NO331198B1 (no) |
NZ (1) | NZ534836A (no) |
PL (1) | PL201898B1 (no) |
RU (1) | RU2255759C2 (no) |
SK (1) | SK3752002A3 (no) |
TR (1) | TR200200738T2 (no) |
TW (1) | TWI267373B (no) |
UA (1) | UA73956C2 (no) |
WO (1) | WO2001021194A2 (no) |
ZA (1) | ZA200201374B (no) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10157628A1 (de) * | 2001-11-26 | 2003-06-12 | Zentaris Ag | Injektionslösung eines LHRH-Antagonisten |
US7214662B2 (en) | 2001-11-27 | 2007-05-08 | Zentaris Gmbh | Injectable solution of an LHRH antagonist |
DK2252627T3 (en) | 2008-01-24 | 2017-08-14 | Esperance Pharmaceuticals | MERGER CONSTRUCTION WITH LYTIC DOMAIN AND METHOD FOR PRODUCING AND USING SAME. |
WO2010085145A1 (en) * | 2009-01-22 | 2010-07-29 | Maatschap Interne Geneeskunde Rijnstate | Method for the prophylaxis or treatment of flushing |
BR112015009752A2 (pt) | 2012-10-30 | 2017-07-11 | Esperance Pharmaceuticals Inc | conjugados de anticorpo/fármaco e métodos de uso |
EP4223298A3 (en) | 2013-03-15 | 2023-08-16 | AbbVie Inc. | Compositions for use in treating heavy menstrual bleeding |
BR112020021276A2 (pt) | 2018-04-19 | 2021-01-26 | Abbvie Inc. | métodos de tratamento de sangramento menstrual intenso |
EP3560555A1 (en) | 2018-04-26 | 2019-10-30 | LifeArc | A composition for treating one or more estrogen related diseases |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5064939A (en) * | 1990-02-06 | 1991-11-12 | The Salk Institute For Biological Studies | Cyclic gnrh antagonists |
SE9301606D0 (sv) * | 1993-05-07 | 1993-05-07 | Per-Christer Oden | Composition for the treatment of impaired hair growth |
US5658884A (en) * | 1994-07-22 | 1997-08-19 | The Medical College Of Hampton Roads | Establishment of tonic ovarian estrogen secretion for extended therapeutic regimens |
EP0769956B1 (en) * | 1994-07-22 | 2000-03-15 | The Medical College Of Hampton Roads | USE OF A GnRH ANTAGONIST FOR THE PREPARATION OF A MEDICAMENT FOR THE TREATMENT OF GONADAL-STEROID CONDITIONS |
DE19513662A1 (de) * | 1995-04-08 | 1996-10-10 | Schering Ag | Pharmazeutisches Kombinationspräparat zur hormonalen Kontrazeption |
DE19604231A1 (de) * | 1996-01-29 | 1997-07-31 | Schering Ag | Pharmazeutisches Kombinationspräparat und seine Verwendung zur Behandlung von gynäkologischen Störungen |
CN1228708A (zh) * | 1996-09-04 | 1999-09-15 | 有限会社多特 | 经口给药用含肽药物组合物 |
AU729752B2 (en) * | 1997-06-05 | 2001-02-08 | Merck & Co., Inc. | Antagonists of gonadotropin releasing hormone |
DE19911771B4 (de) * | 1999-03-17 | 2006-03-30 | Zentaris Gmbh | LHRH-Antagonist, Verfahren zu seiner Herstellung und seiner Verwendung |
-
2000
- 2000-09-20 CA CA002383510A patent/CA2383510A1/en not_active Abandoned
- 2000-09-20 CN CN00813196A patent/CN1376070A/zh active Pending
- 2000-09-20 EP EP00967722A patent/EP1214086A2/en not_active Withdrawn
- 2000-09-20 PL PL353244A patent/PL201898B1/pl not_active IP Right Cessation
- 2000-09-20 KR KR1020027003740A patent/KR100772852B1/ko not_active IP Right Cessation
- 2000-09-20 WO PCT/EP2000/009212 patent/WO2001021194A2/en active IP Right Grant
- 2000-09-20 CN CNA2007100789192A patent/CN101045155A/zh active Pending
- 2000-09-20 JP JP2001524618A patent/JP2003509467A/ja not_active Withdrawn
- 2000-09-20 SK SK375-2002A patent/SK3752002A3/sk not_active Application Discontinuation
- 2000-09-20 NZ NZ534836A patent/NZ534836A/en not_active IP Right Cessation
- 2000-09-20 IL IL14818500A patent/IL148185A0/xx not_active IP Right Cessation
- 2000-09-20 HU HU0202741A patent/HUP0202741A3/hu unknown
- 2000-09-20 TR TR2002/00738T patent/TR200200738T2/xx unknown
- 2000-09-20 BR BR0014198-4A patent/BR0014198A/pt not_active Application Discontinuation
- 2000-09-20 RU RU2002111000/14A patent/RU2255759C2/ru not_active IP Right Cessation
- 2000-09-20 MX MXPA02002436A patent/MXPA02002436A/es active IP Right Grant
- 2000-09-20 UA UA2002043346A patent/UA73956C2/uk unknown
- 2000-09-20 AU AU77792/00A patent/AU769482B2/en not_active Ceased
- 2000-09-22 TW TW089119671A patent/TWI267373B/zh not_active IP Right Cessation
-
2002
- 2002-02-19 ZA ZA200201374A patent/ZA200201374B/en unknown
- 2002-03-21 NO NO20021430A patent/NO331198B1/no not_active IP Right Cessation
- 2002-04-05 BG BG106584A patent/BG66128B1/bg unknown
-
2003
- 2003-02-18 HK HK03101215.4A patent/HK1049117A1/zh unknown
-
2011
- 2011-10-17 JP JP2011227603A patent/JP2012051920A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
NO20021430L (no) | 2002-05-07 |
JP2003509467A (ja) | 2003-03-11 |
JP2012051920A (ja) | 2012-03-15 |
SK3752002A3 (en) | 2003-06-03 |
IL148185A0 (en) | 2002-09-12 |
BG106584A (bg) | 2003-02-28 |
NO331198B1 (no) | 2011-10-31 |
BR0014198A (pt) | 2002-05-21 |
PL353244A1 (en) | 2003-11-03 |
RU2255759C2 (ru) | 2005-07-10 |
ZA200201374B (en) | 2002-10-30 |
NZ534836A (en) | 2007-07-27 |
PL201898B1 (pl) | 2009-05-29 |
KR100772852B1 (ko) | 2007-11-02 |
TR200200738T2 (tr) | 2002-08-21 |
NO20021430D0 (no) | 2002-03-21 |
HUP0202741A3 (en) | 2003-12-29 |
WO2001021194A2 (en) | 2001-03-29 |
MXPA02002436A (es) | 2003-02-12 |
BG66128B1 (bg) | 2011-06-30 |
HK1049117A1 (zh) | 2003-05-02 |
UA73956C2 (en) | 2005-10-17 |
TWI267373B (en) | 2006-12-01 |
AU7779200A (en) | 2001-04-24 |
AU769482B2 (en) | 2004-01-29 |
EP1214086A2 (en) | 2002-06-19 |
WO2001021194A3 (en) | 2002-03-14 |
CN101045155A (zh) | 2007-10-03 |
CN1376070A (zh) | 2002-10-23 |
KR20020035879A (ko) | 2002-05-15 |
HUP0202741A2 (hu) | 2003-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3130048B2 (ja) | エストロゲン依存症の治療 | |
ES2281551T3 (es) | Metodo de prevencion o tratamiento de enfermedades ginecologicas benignas. | |
Erkkola et al. | Role of progestins in contraception | |
JP2012051920A (ja) | 子宮内膜組織の子宮外の増殖、慢性骨盤痛およびファロピウス管閉塞症を治療するための製剤学的組成物、前述の疾病を治療するための医薬を製造するためのlhrhアンタゴニスト又はlhrhアンタゴニストおよび活性剤の使用 | |
US7666836B2 (en) | Method for the therapeutic management of endometriosis | |
JP2010539153A (ja) | 閉経前の女性におけるエストロゲン依存症状の治療 | |
TW577735B (en) | Pharmaceutical combined preparation and its use in the treatment of gynaecological disorders | |
Bedaiwy et al. | Aromatase inhibitors prevent the estrogen rise associated with the flare effect of gonadotropins in patients treated with GnRH agonists | |
La Marca et al. | Gestrinone in the treatment of uterine leiomyomata: effects on uterine blood supply | |
JP2012077020A (ja) | ゲスターゲンとGnRHアンタゴニストとの組合せ医薬 | |
Bergqvist | Current drug therapy recommendations for the treatment of endometriosis | |
BG106442A (bg) | Мезопрогестини (прогестерон рецептор модулатори) за лечение и профилактика на хормонозависими доброкачествени гинекологични заболявания | |
JP3925688B2 (ja) | GnRHa治療中および/またはGnRHa治療後の副作用を治療するための製薬学的調剤 | |
BR112020021565A2 (pt) | Composição para tratamento de uma ou mais doenças relacionadas com estrogênio | |
Magyar et al. | Effect of hormone replacement therapy on postmenopausal endometrial bleeding | |
Wong et al. | Exogenous Hormone-Induced Endometrial Changes | |
Patel | Response of the Uterus to Medication: Hysteroscopic Implications | |
Patel | 6 Hysteroscopic Implications |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Discontinued |
Effective date: 20130605 |